Login
$ARDX
$3.09 +$0.02 (0.65%) After hours

$ARDX SEC Filings

Filed On Filing
03 Nov 2026 10-Q
03 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Q3 2026 total product revenue of $125.5 million, reflecting 19% growth year-over-year

25 Aug 2026 Form 4: Hohenleitner Susan, Chief Financial Officer

Sold 1,558 shares ($6.01K)

25 Aug 2026 Form 4: Reilly Joseph James, See Remarks

Sold 3,982 shares ($15.4K)

25 Aug 2026 Form 4: Bishop John E, See Remarks

Sold 19,750 shares ($76.2K)

25 Aug 2026 Form 4: Brady James Parker, Chief Human Resources Officer

Sold 15,136 shares ($58.4K)

25 Aug 2026 Form 4: Foster Eric Duane, Chief Commercial Officer

Sold 8,562 shares ($33K)

25 Aug 2026 Form 4: Kelliher Mike, Chief Business Officer

Sold 7,758 shares ($29.9K)

25 Aug 2026 Form 4: Williams Laura A, Chief Patient Officer

Sold 10,739 shares ($41.4K)

25 Aug 2026 Form 4: Raab Michael, Director

Sold 58,574 shares ($226K)

21 Aug 2026 144
21 Aug 2026 144
21 Aug 2026 144
21 Aug 2026 144
21 Aug 2026 144
21 Aug 2026 144
21 Aug 2026 144
21 Aug 2026 144
17 Aug 2026 8-K: Other Events

On August 11, 2026, Eric Foster notified Ardelyx, Inc. (the “Company”) of his decision to resign as Chief Commercial Officer of the Company, effective August 28, 2026. Mr. Foster resigned to pursue a new opportunity with a pre-commercial...

14 Aug 2026 SCHEDULE 13G

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support